{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:37:49Z","timestamp":1785893869321,"version":"3.56.0"},"posted":{"date-parts":[[2026,1,29]]},"group-title":"In Review","reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,16]]},"abstract":"<title>Abstract<\/title>\n                <p>Background\n Pediatric neuromuscular diseases are genetically and clinically heterogeneous. A substantial proportion remain without a definitive genetic diagnosis despite available clinical molecular testing. RNA-sequencing (RNA-seq) can be used to complement genome or exome sequencing to elucidate or to identify the functional impact of variants of uncertain significance, but when manually analyzed is limited to candidate DNA variants or phenotype-driven gene lists. Open-source computational tools have been developed to systematically and unbiasedly analyze RNA-seq data for aberrant splicing, expression, or allelic imbalance. However, best use practice of these tools is yet to be established.\nMethods\n To assess the performance of selected tools, we collected RNA-seq from 97 previously diagnosed samples to establish a truth set for benchmarking. Pathogenic variants were categorized as: true positives with confirmed aberrant RNA events and true negatives with no transcriptomic effect. We assessed performance of eight commonly used tools for splicing, expression and allelic imbalance analysis. We then applied the optimal strategy to 74 undiagnosed RNA-seq samples to identify new candidate diagnoses.\nResults\n Across 68 diagnosed probands with aberrant RNA events, tools correctly identified 28 diagnoses. Splicing analysis tools provided most of the findings, but allelic imbalance tools uniquely identified 4, underscoring their value. Conversely, the false positive rate was highest for the splice tools and lowest for expression analysis. Application of tools led to identification of candidate variants for only 9 out of 74 undiagnosed patients.\nConclusions\n Inclusion of RNA-seq tools can expedite variant prioritization, characterization and interpretation in the diagnostic pipeline but remain complementary to manual analysis of loci where candidate variants were identified by DNA sequencing.<\/p>","DOI":"10.21203\/rs.3.rs-8622051\/v1","type":"posted-content","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:53:52Z","timestamp":1769648032000},"source":"Crossref","is-referenced-by-count":1,"title":["Benchmarking RNA-seq Tools for Real-World Diagnostic Applications"],"prefix":"10.21203","author":[{"given":"Sarah","family":"Silverstein","sequence":"first","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Ganapathy","sequence":"additional","affiliation":[{"name":"Scripps Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Donkervoort","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bolduc","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Moy","sequence":"additional","affiliation":[{"name":"Boston University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prech","family":"Uapinyoying","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Gorokhova","sequence":"additional","affiliation":[{"name":"Aix-Marseille University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Ganesh","sequence":"additional","affiliation":[{"name":"Broad Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Weisburd","sequence":"additional","affiliation":[{"name":"Broad Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotem","family":"OrBach","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Reghan","family":"Foley","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Seattle Children's Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adams","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Bonnemann","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/J.NMD.2021.07.009","article-title":"Congenital muscular dystrophies: What is new? Neuromuscular Disorders","volume":"31","author":"Zambon AA","year":"2021","unstructured":"Zambon AA, Muntoni F. Congenital muscular dystrophies: What is new? Neuromuscular Disorders. Elsevier. 2021;31:931\u201342. https:\/\/doi.org\/10.1016\/J.NMD.2021.07.009.","journal-title":"Elsevier"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/BRAIN\/AWAC452","author":"Zambon AA","year":"2023","unstructured":"Zambon AA, Pini V, Bosco L, Falzone YM, Munot P, Muntoni F et al. Early onset hereditary neuronopathies: an update on non-5q motor neuron diseases. Brain [Internet]. Oxford Academic; 2023 [cited 2024 Jan 9];146:806\u201322. https:\/\/doi.org\/10.1093\/BRAIN\/AWAC452"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1212\/WNL.0000000000001416","article-title":"Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine","volume":"84","author":"Kang PB","year":"2015","unstructured":"Kang PB, Morrison L, Iannaccone ST, Graham RJ, B\u00f6nnemann CG, Rutkowski A, et al. Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurol [Internet] Neurol. 2015;84:1369\u201378. https:\/\/doi.org\/10.1212\/WNL.0000000000001416. [cited 2023 Dec 13];.","journal-title":"Neurol [Internet] Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.NMD.2013.01.004","article-title":"Congenital myopathies\u2013clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromuscul Disord [Internet]","volume":"23","author":"Maggi L","year":"2013","unstructured":"Maggi L, Scoto M, Cirak S, Robb SA, Klein A, Lillis S et al. Congenital myopathies\u2013clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromuscul Disord [Internet]. Neuromuscul Disord; 2013 [cited 2024 Jan 8];23:195\u2013205. https:\/\/doi.org\/10.1016\/J.NMD.2013.01.004"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ACN3.70078","author":"Segarra-Casas A","year":"2025","unstructured":"Segarra-Casas A, Dom\u00ednguez-Gonz\u00e1lez C, Natera-de Benito D, Kapetanovic S, Hern\u00e1ndez-La\u00edn A, Est\u00e9vez-Arias B et al. Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases. Ann Clin Transl Neurol [Internet]. John Wiley and Sons Inc; 2025 [cited 2025 Jun 25];0:1\u201315. https:\/\/doi.org\/10.1002\/ACN3.70078;REQUESTEDJOURNAL:JOURNAL:23289503;JOURNAL:JOURNAL:23289503;WGROUP:STRING:PUBLICATION."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/S12967-025-06609-W","author":"Luo X","year":"2025","unstructured":"Luo X, Xiao B, Liang L, Zhang K, Xu T, Liu H et al. Blood RNA-seq in rare disease diagnostics: a comparative study of cases with and without candidate variants. J Transl Med [Internet]. BioMed Central Ltd; 2025 [cited 2025 Jun 25];23. https:\/\/doi.org\/10.1186\/S12967-025-06609-W."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13073-024-01381-W\/FIGURES\/6","article-title":"Identification of diagnostic candidates in Mendelian disorders using an RNA sequencing-centric approach","volume":"16","author":"Jaramillo Oquendo C","year":"2024","unstructured":"Jaramillo Oquendo C, Wai HA, Rich WI, Bunyan DJ, Thomas NS, Hunt D, et al. Identification of diagnostic candidates in Mendelian disorders using an RNA sequencing-centric approach. Genome Med [Internet] BioMed. 2024;16:1\u201319. https:\/\/doi.org\/10.1186\/S13073-024-01381-W\/FIGURES\/6. [cited 2025 Jun 25];. Central Ltd.","journal-title":"Genome Med [Internet] BioMed"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41591-019-0457-8","article-title":"Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts","volume":"25","author":"Fr\u00e9sard L","year":"2019","unstructured":"Fr\u00e9sard L, Smail C, Ferraro NM, Teran NA, Li X, Smith KS, et al. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts. Nat Med Nat Res. 2019;25:911\u20139. https:\/\/doi.org\/10.1038\/s41591-019-0457-8.","journal-title":"Nat Med Nat Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ncomms15824","article-title":"Genetic diagnosis of Mendelian disorders via RNA sequencing","author":"Kremer LS","year":"2017","unstructured":"Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, Iuso A, et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun Nat Publishing Group. 2017;8. https:\/\/doi.org\/10.1038\/ncomms15824.","journal-title":"Nat Commun Nat Publishing Group"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal5209","author":"Cummings BB","year":"2017","unstructured":"Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med [Internet]. American Association for the Advancement of Science; 2017 [cited 2024 Jan 16];9. https:\/\/doi.org\/10.1126\/scitranslmed.aal5209"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141500","author":"Murdock DR","year":"2021","unstructured":"Murdock DR, Dai H, Burrage LC, Rosenfeld JA, Ketkar S, M\u00fcller MF et al. Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing. J Clin Invest [Internet]. American Society for Clinical Investigation; 2021 [cited 2024 Jan 16];131. https:\/\/doi.org\/10.1172\/JCI141500"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/J.AJHG.2019.01.012","article-title":"Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease","volume":"104","author":"Gonorazky HD","year":"2019","unstructured":"Gonorazky HD, Naumenko S, Ramani AK, Nelakuditi V, Mashouri P, Wang P, et al. Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease. Am J Hum Genet [Internet] Am J Hum Genet. 2019;104:466\u201383. https:\/\/doi.org\/10.1016\/J.AJHG.2019.01.012. [cited 2024 Jan 16];.","journal-title":"Am J Hum Genet [Internet] Am J Hum Genet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/S41436-019-0672-1","article-title":"Diagnostic utility of transcriptome sequencing for rare Mendelian diseases","volume":"22","author":"Lee H","year":"2020","unstructured":"Lee H, Huang AY, Wang L, kai, Yoon AJ, Renteria G, Eskin A, et al. Diagnostic utility of transcriptome sequencing for rare Mendelian diseases. Genet Med Elsevier. 2020;22:490\u20139. https:\/\/doi.org\/10.1038\/S41436-019-0672-1.","journal-title":"Genet Med Elsevier"},{"key":"ref14","author":"Y\u00e9pez VA","year":"2022","unstructured":"Y\u00e9pez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, et al. Clinical implementation of RNA sequencing for Mendelian disease diagnostics. Genome Med. 2022;14:1\u201326. https:\/\/doi.org\/10.1186\/S13073-022-01019-9. [cited 2022 May 4];. 2022 14:1 [Internet]BioMed Central."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/S41525-025-00502-7","article-title":"Cracking rare disorders: a new minimally invasive RNA-seq protocol","volume":"10","author":"Cock L","year":"2025","unstructured":"De Cock L, D\u2019haenens E, Vantomme L, Backers L, Beyens A, Claes KB, et al. Cracking rare disorders: a new minimally invasive RNA-seq protocol. NPJ Genom Med [Internet] NPJ. 2025;10:45. https:\/\/doi.org\/10.1038\/S41525-025-00502-7. [cited 2025 Jun 25];. Genom Med.","journal-title":"NPJ Genom Med [Internet] NPJ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/JMG-2023-109263","article-title":"Integrating RNA-Seq into genome sequencing workflow enhances the analysis of structural variants causing neurodevelopmental disorders","volume":"61","author":"Riquin K","year":"2023","unstructured":"Riquin K, Isidor B, Mercier S, Nizon M, Colin E, Bonneau D, et al. Integrating RNA-Seq into genome sequencing workflow enhances the analysis of structural variants causing neurodevelopmental disorders. J Med Genet [Internet] BMJ. 2023;61:47\u201356. https:\/\/doi.org\/10.1136\/JMG-2023-109263. [cited 2025 Jun 25];. Publishing Group.","journal-title":"J Med Genet [Internet] BMJ"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ajhg.2022.12.015","article-title":"Web-accessible application for identifying pathogenic transcripts with RNA-seq: Increased sensitivity in diagnosis of neurodevelopmental disorders","volume":"110","author":"Dekker J","year":"2023","unstructured":"Dekker J, Schot R, Bongaerts M, de Valk WG, van Veghel-Plandsoen MM, Monfils K, et al. Web-accessible application for identifying pathogenic transcripts with RNA-seq: Increased sensitivity in diagnosis of neurodevelopmental disorders. Am J Hum Genet [Internet] Cell Press. 2023;110:251\u201372. https:\/\/doi.org\/10.1016\/j.ajhg.2022.12.015. [cited 2025 Jun 25];.","journal-title":"Am J Hum Genet [Internet] Cell Press"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/J.GIM.2021.09.001","article-title":"Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants","volume":"24","author":"Bournazos AM","year":"2022","unstructured":"Bournazos AM, Riley LG, Bommireddipalli S, Ades L, Akesson LS, Al-Shinnag M, et al. Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants. Genet Med Elsevier. 2022;24:130\u201345. https:\/\/doi.org\/10.1016\/J.GIM.2021.09.001.","journal-title":"Genet Med Elsevier"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/S41596-023-00944-2","author":"Wang Y","year":"2024","unstructured":"Wang Y, Xie Z, Kutschera E, Adams JI, Kadash-Edmondson KE, Xing Y. rMATS-turbo: an efficient and flexible computational tool for alternative splicing analysis of large-scale RNA-seq data. Nat Protoc [Internet]. Springer Nature; 2024 [cited 2025 Jun 25];19:1083\u2013104. https:\/\/doi.org\/10.1038\/S41596-023-00944-2."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.ajhg.2023.10.014","article-title":"Improved detection of aberrant splicing with FRASER 2.0 and the intron Jaccard index","volume":"110","author":"Scheller IF","year":"2023","unstructured":"Scheller IF, Lutz K, Mertes C, Y\u00e9pez VA, Gagneur J. Improved detection of aberrant splicing with FRASER 2.0 and the intron Jaccard index. Am J Hum Genet [Internet] Cell Press. 2023;110:2056\u201367. https:\/\/doi.org\/10.1016\/j.ajhg.2023.10.014. [cited 2025 Jun 25];.","journal-title":"Am J Hum Genet [Internet] Cell Press"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/J.AJHG.2018.10.025","article-title":"OUTRIDER: A Statistical Method for Detecting Aberrantly Expressed Genes in RNA Sequencing Data","volume":"103","author":"Brechtmann F","year":"2018","unstructured":"Brechtmann F, Mertes C, Matusevi\u010di\u016bt\u0117 A, Y\u00e9pez VA, Avsec \u017d, Herzog M, et al. OUTRIDER: A Statistical Method for Detecting Aberrantly Expressed Genes in RNA Sequencing Data. Am J Hum Genet [Internet] Am J Hum Genet. 2018;103:907\u201317. https:\/\/doi.org\/10.1016\/J.AJHG.2018.10.025. [cited 2024 Feb 5];.","journal-title":"Am J Hum Genet [Internet] Am J Hum Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13059-021-02507-8\/TABLES\/2","author":"Cmero M","year":"2021","unstructured":"Cmero M, Schmidt B, Majewski IJ, Ekert PG, Oshlack A, Davidson NM. MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data. Genome Biol [Internet]. BioMed Central Ltd; 2021 [cited 2024 Feb 5];22:1\u201326. https:\/\/doi.org\/10.1186\/S13059-021-02507-8\/TABLES\/2"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20573-7","author":"Mertes C","year":"2021","unstructured":"Mertes C, Scheller IF, Y\u00e9pez VA, \u00c7elik MH, Liang Y, Kremer LS et al. Detection of aberrant splicing events in RNA-seq data using FRASER. Nature Communications 2021 12:1 [Internet]. Nature Publishing Group; 2021 [cited 2024 Feb 5];12:1\u201313. https:\/\/doi.org\/10.1038\/s41467-020-20573-7"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-020-00462-5","author":"Y\u00e9pez VA","year":"2021","unstructured":"Y\u00e9pez VA, Mertes C, M\u00fcller MF, Klaproth-Andrade D, Wachutka L, Fr\u00e9sard L et al. Detection of aberrant gene expression events in RNA sequencing data. Nature Protocols 2021 16:2 [Internet]. Nature Publishing Group; 2021 [cited 2024 Jan 24];16:1276\u201396. https:\/\/doi.org\/10.1038\/s41596-020-00462-5"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ajhg.2025.02.006","article-title":"Clinical validation of RNA sequencing for Mendelian disorder diagnostics","volume":"112","author":"Zhao S","year":"2025","unstructured":"Zhao S, Macakova K, Sinson JC, Dai H, Rosenfeld J, Zapata GE, et al. Clinical validation of RNA sequencing for Mendelian disorder diagnostics. Am J Hum Genet [Internet] Cell Press. 2025;112:779\u201392. https:\/\/doi.org\/10.1016\/j.ajhg.2025.02.006. [cited 2025 Jun 30];.","journal-title":"Am J Hum Genet [Internet] Cell Press"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/JMEDGENET-2021-108013","article-title":"RNA splicing analysis contributes to reclassifying variants of uncertain significance and improves the diagnosis of monogenic disorders","volume":"59","author":"He W","year":"2022","unstructured":"He W, Bin, Xiao WJ, Dai CL, Wang YR, Li XR, Gong F, et al. RNA splicing analysis contributes to reclassifying variants of uncertain significance and improves the diagnosis of monogenic disorders. J Med Genet [Internet] BMJ. 2022;59:1010\u20136. https:\/\/doi.org\/10.1136\/JMEDGENET-2021-108013. [cited 2025 Jun 29];. Publishing Group.","journal-title":"J Med Genet [Internet] BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/S13073-025-01494-W","author":"Stark JC","year":"2025","unstructured":"Stark JC, Pipko N, Liang Y, Szuto A, Ting Tsoi C, Dickson MA et al. Clinical applications of and molecular insights from RNA sequencing in a rare disease cohort. Genome Medicine 2025 17:1 [Internet]. BioMed Central; 2025 [cited 2025 Jul 14];17:1\u201324. https:\/\/doi.org\/10.1186\/S13073-025-01494-W"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/S12920-025-02227-Z","author":"Lewis RG","year":"2025","unstructured":"Lewis RG, O\u2019Shea JM, Pizzo L, Wen T, Fulmer ML, Zhao J et al. RNA sequencing provides functional insights and diagnostic resolution in previously unsolved rare disease cases. BMC Medical Genomics. 2025 18:1 [Internet]. BioMed Central; 2025 [cited 2025 Nov 16];18:182-. https:\/\/doi.org\/10.1186\/S12920-025-02227-Z"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/BIOINFORMATICS\/BTS635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin A","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: Ultrafast universal RNA-seq aligner. Bioinf [Internet] Bioinf. 2013;29:15\u201321. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS635. [cited 2025 Jun 25];.","journal-title":"Bioinf [Internet] Bioinf"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/BIOINFORMATICS\/BTS196","author":"Deluca DS","year":"2012","unstructured":"Deluca DS, Levin JZ, Sivachenko A, Fennell T, Nazaire MD, Williams C et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics [Internet]. Bioinformatics; 2012 [cited 2024 Feb 19];28:1530\u20132. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS196"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/NBT.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson JT","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol [Internet] Nat Biotechnol. 2011;29:24\u20136. https:\/\/doi.org\/10.1038\/NBT.1754. [cited 2025 Jun 25];.","journal-title":"Nat Biotechnol [Internet] Nat Biotechnol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir H","year":"2013","unstructured":"Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178\u201392. https:\/\/doi.org\/10.1093\/bib\/bbs017.","journal-title":"Brief Bioinform"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"a006198","DOI":"10.1101\/MCS.A006198","article-title":"Toward transcriptomics as a primary tool for rare disease investigation. Cold Spring Harb Mol Case Stud [Internet]","volume":"8","author":"Montgomery SB","year":"2022","unstructured":"Montgomery SB, Bernstein JA, Wheeler MT. Toward transcriptomics as a primary tool for rare disease investigation. Cold Spring Harb Mol Case Stud [Internet]. Cold Spring Harbor Laboratory Press; 2022 [cited 2025 Jun 26];8:a006198. https:\/\/doi.org\/10.1101\/MCS.A006198"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1093\/BIOINFORMATICS\/BTAA259","article-title":"LeafCutterMD: an algorithm for outlier splicing detection in rare diseases","volume":"36","author":"Jenkinson G","year":"2020","unstructured":"Jenkinson G, Li YI, Basu S, Cousin MA, Oliver GR, Klee EW. LeafCutterMD: an algorithm for outlier splicing detection in rare diseases. Bioinf [Internet] Bioinf. 2020;36:4609\u201315. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTAA259. [cited 2022 Nov 3];.","journal-title":"Bioinf [Internet] Bioinf"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-017-0004-9","author":"Li YI","year":"2017","unstructured":"Li YI, Knowles DA, Humphrey J, Barbeira AN, Dickinson SP, Im HK et al. Annotation-free quantification of RNA splicing using LeafCutter. Nature Genetics. 2017 50:1 [Internet]. Nature Publishing Group; 2017 [cited 2022 Aug 21];50:151\u20138. https:\/\/doi.org\/10.1038\/s41588-017-0004-9"},{"key":"ref36","author":"Ganapathy KR","year":"2025","unstructured":"Ganapathy KR, Broly M, Silverstein S, Mendoza M, Song E, Kotis B et al. Improved Identification of Large-effect Rare Genetic Variants using Haplotype Aggregated Allele-specific Expression Data. medRxiv [Internet]. Cold Spring Harbor Laboratory Press; 2025 [cited 2026 Jan 4];2025.12.16.25341855. https:\/\/doi.org\/10.64898\/2025.12.16.25341855."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/NG.3679","article-title":"Reference-based phasing using the Haplotype Reference Consortium panel","volume":"48","author":"Loh PR","year":"2016","unstructured":"Loh PR, Danecek P, Palamara PF, Fuchsberger C, Reshef YA, Finucane HK, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet [Internet] Nat Publishing Group. 2016;48:1443\u20138. https:\/\/doi.org\/10.1038\/NG.3679. [cited 2025 Jun 25];.","journal-title":"Nat Genet [Internet] Nat Publishing Group"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/J.CELL.2022.08.004","article-title":"High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios","volume":"185","author":"Byrska-Bishop M","year":"2022","unstructured":"Byrska-Bishop M, Evani US, Zhao X, Basile AO, Abel HJ, Regier AA, et al. High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios. Cell [Internet] Elsevier. 2022;185:3426\u2013e344019. https:\/\/doi.org\/10.1016\/J.CELL.2022.08.004. [cited 2025 Jun 25];. B.V.","journal-title":"Cell [Internet] Elsevier"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"12817","DOI":"10.1038\/NCOMMS12817","article-title":"Rare variant phasing and haplotypic expression from RNA sequencing with phASER","volume":"7","author":"Castel SE","year":"2016","unstructured":"Castel SE, Mohammadi P, Chung WK, Shen Y, Lappalainen T. Rare variant phasing and haplotypic expression from RNA sequencing with phASER. Nat Commun [Internet] Nat Publishing Group. 2016;7:12817. https:\/\/doi.org\/10.1038\/NCOMMS12817. [cited 2025 Jun 25];.","journal-title":"Nat Commun [Internet] Nat Publishing Group"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.AAY0256\/SUPPL_FILE\/AAY0256_TABLES5.XLSX","author":"Mohammadi P","year":"1979","unstructured":"Mohammadi P, Castel SE, Cummings BB, Einson J, Sousa C, Hoffman P et al. Genetic regulatory variation in populations informs transcriptome analysis in rare disease. Science (1979) [Internet]. American Association for the Advancement of Science; 2019 [cited 2025 Jun 25];366:351\u20136. https:\/\/doi.org\/10.1126\/SCIENCE.AAY0256\/SUPPL_FILE\/AAY0256_TABLES5.XLSX"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13059-016-0974-4\/TABLES\/8","author":"McLaren W","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A et al. The Ensembl Variant Effect Predictor. Genome Biol [Internet]. BioMed Central Ltd.; 2016 [cited 2025 Sep 14];17:1\u201314. https:\/\/doi.org\/10.1186\/S13059-016-0974-4\/TABLES\/8"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume-title":"Predicting Splicing from Primary Sequence with Deep Learning. Cell [Internet]","author":"Jaganathan K","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell [Internet]. Volume 176. Cell; 2019. pp. 535\u2013e54824. [cited 2025 Nov 4];. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/HUMU.24366","author":"Pais LS","year":"2022","unstructured":"Pais LS, Snow H, Weisburd B, Zhang S, Baxter SM, DiTroia S et al. seqr: A web-based analysis and collaboration tool for rare disease genomics. Hum Mutat [Internet]. John Wiley and Sons Inc; 2022 [cited 2025 Jun 25];43:698\u2013707. https:\/\/doi.org\/10.1002\/HUMU.24366."},{"key":"ref44","author":"Sobreira N","year":"2015","unstructured":"Sobreira N, Schiettecatte F, Valle D, Hamosh A, GeneMatcher:. A Matching Tool for Connecting Investigators with an Interest in the Same Gene. Volume 36. John Wiley and Sons Inc.; 2015. pp. 928\u201330. [cited 2025 Sep 14];. https:\/\/doi.org\/10.1002\/HUMU.22844. Hum Mutat [Internet]."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.ajhg.2024.05.005","article-title":"Impact of genome build on RNA-seq interpretation and diagnostics","volume":"111","author":"Ungar RA","year":"2024","unstructured":"Ungar RA, Goddard PC, Jensen TD, Degalez F, Smith KS, Jin CA, et al. Impact of genome build on RNA-seq interpretation and diagnostics. Am J Hum Genet [Internet] Cell Press. 2024;111:1282\u2013300. https:\/\/doi.org\/10.1016\/j.ajhg.2024.05.005. [cited 2025 Jul 1];.","journal-title":"Am J Hum Genet [Internet] Cell Press"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bbagrm.2013.03.002","article-title":"Regulation of nonsense-mediated mRNA decay: Implications for physiology and disease. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms","volume":"1829","author":"Karam R","year":"2013","unstructured":"Karam R, Wengrod J, Gardner LB, Wilkinson MF. Regulation of nonsense-mediated mRNA decay: Implications for physiology and disease. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2013;1829:624\u201333. https:\/\/doi.org\/10.1016\/j.bbagrm.2013.03.002"},{"key":"ref47","author":"Cassini T","year":"2025","unstructured":"Cassini T, Silverstein S, Behan M, Tifft CJ, Malicdan MC, Adams DR, et al. Mitochondrial trifunctional protein deficiency caused by a deep intronic deletion leading to aberrant splicing. John Wiley and Sons Inc; 2025. [cited 2025 Jul 1];66. https:\/\/doi.org\/10.1002\/JMD2.12459. JIMD Rep [Internet]."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109105","author":"Silverstein S","year":"2025","unstructured":"Silverstein S, Cassini T, Fu J, Pusey B, Macnamara E, Frost FG et al. RNA sequencing driven diagnosis expands the phenotypic spectrum of NBAS deficiency. Mol Genet Metab [Internet]. Academic Press Inc.; 2025 [cited 2025 Jul 1];145. https:\/\/doi.org\/10.1016\/j.ymgme.2025.109105"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1126\/science.aaz5900","article-title":"Transcriptomic signatures across human tissues identify functional rare genetic variation","author":"Ferraro NM","year":"2020","unstructured":"Ferraro NM, Strober BJ, Einson J, Abell NS, Aguet F, Barbeira AN, et al. Transcriptomic signatures across human tissues identify functional rare genetic variation. Science. 2020;369. https:\/\/doi.org\/10.1126\/science.aaz5900.","journal-title":"Science"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/NG.3837","article-title":"Pathogenic variants that alter protein code often disrupt splicing","volume":"49","author":"Soemedi R","year":"2017","unstructured":"Soemedi R, Cygan KJ, Rhine CL, Wang J, Bulacan C, Yang J, et al. Pathogenic variants that alter protein code often disrupt splicing. Nat Genet [Internet] Nat Genet. 2017;49:848\u201355. https:\/\/doi.org\/10.1038\/NG.3837. [cited 2025 Nov 4];.","journal-title":"Nat Genet [Internet] Nat Genet"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.molcel.2018.10.037","author":"Chong R","year":"2019","unstructured":"Chong R, Insigne KD, Yao D, Burghard CP, Wang J, Hsiao YHE et al. A Multiplexed Assay for Exon Recognition Reveals that an Unappreciated Fraction of Rare Genetic Variants Cause Large-Effect Splicing Disruptions. Mol Cell [Internet]. Cell; 2019 [cited 2025 Nov 4];73:183\u2013e1948. https:\/\/doi.org\/10.1016\/j.molcel.2018.10.037"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e1011412","DOI":"10.1371\/JOURNAL.PGEN.1011412","article-title":"Prioritizing disease-related rare variants by integrating gene expression data","volume":"20","author":"Guo H","year":"2024","unstructured":"Guo H, Urban AE, Wong WH. Prioritizing disease-related rare variants by integrating gene expression data. PLoS Genet [Internet] Public Libr Sci. 2024;20:e1011412. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1011412. [cited 2025 Sep 1];.","journal-title":"PLoS Genet [Internet] Public Libr Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.02.24318941","author":"Arriaga MT","year":"2025","unstructured":"Arriaga MT, Mendez R, Ungar RA, Bonner DE, Matalon DR, Lemire G et al. Transcriptome-wide outlier approach identifies individuals with minor spliceopathies. medRxiv [Internet]. medRxiv; 2025 [cited 2025 Sep 15]; https:\/\/doi.org\/10.1101\/2025.01.02.24318941"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8622051\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8622051\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:54:25Z","timestamp":1769648065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8622051\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":53,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8622051\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,1,29]]},"subtype":"preprint"}}